What's in Raphaelle Jaquet-Pilloud's pipeline?

Raphaelle Jaquet-Pilloud has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Raphaelle Jaquet-Pilloud's portfolio?

Top competitors by shared drug class: Ministry of Health, Spain.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/raphaelle-jaquet-pilloud.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Raphaelle Jaquet-Pilloud — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Raphaelle Jaquet-Pilloud pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
NaCl 3%	NaCl 3%	phase 3	Osmotic agent / Hypertonic saline		Neurology / Critical Care

Therapeutic area mix

Neurology / Critical Care · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ministry of Health, Spain · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Raphaelle Jaquet-Pilloud:

Cite this brief

Drug Landscape (2026). Raphaelle Jaquet-Pilloud — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/raphaelle-jaquet-pilloud. Accessed 2026-06-09.